< 1 minute read
Oct. 1, 2021

AZD8154

inhaled dual PI3Kγ,δ kinase inhibitor Ph. II (3 mg QD) for asthma; withdrawn from re-opt. of oral PI3Kγ inhibitor Journal of Medicinal Chemistry AstraZeneca, Gothenburg, SE

drughunter.com
Drug Hunter Team
Loading...

twitterlinkedinemail

Other molecules you may be interested in